Pages that link to "Q37882741"

The following pages link to NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies (Q37882741):

Displaying 45 items.

• Role of endoplasmic reticulum stress in drug-induced toxicity (Q26765518) (← links)
• Multiple NSAID-induced hits injure the small intestine: underlying mechanisms and novel strategies (Q27000132) (← links)
• Role of dietary polyphenols in the management of peptic ulcer (Q28088459) (← links)
• Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence (Q28482202) (← links)
• In vivo imaging reveals PKA regulation of ERK activity during neutrophil recruitment to inflamed intestines (Q33702929) (← links)
• Hydrogen Sulfide: An Endogenous Mediator of Resolution of Inflammation and Injury (Q34226230) (← links)
• Rebamipide helps defend against nonsteroidal anti-inflammatory drugs induced gastroenteropathy: a systematic review and meta-analysis (Q34606022) (← links)
• Understanding and modulating mammalian-microbial communication for improved human health (Q35026463) (← links)
• Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota. (Q35314338) (← links)
• NSAID enteropathy and bacteria: a complicated relationship. (Q35540435) (← links)
• Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage. (Q35660108) (← links)
• Toll-Like Receptor 4 Wild Type Homozygozity of Polymorphisms 896 and 1196 Is Associated with High Gastrin Serum Levels and Peptic Ulcer Risk. (Q35687790) (← links)
• The influence of non-steroidal anti-inflammatory drugs on the gut microbiome (Q35813554) (← links)
• The microbiota-derived metabolite indole decreases mucosal inflammation and injury in a murine model of NSAID enteropathy (Q37082691) (← links)
• Bacterial β-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics (Q37679135) (← links)
• Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy (Q38097424) (← links)
• Polypharmacy of osteoarthritis: the perfect intestinal storm (Q38124006) (← links)
• Histopathological changes in the gastrointestinal tract due to drugs: an update for the surgical pathologist (part I of II). (Q38136048) (← links)
• Recent Advances in NSAIDs-Induced Enteropathy Therapeutics: New Options, New Challenges (Q38155495) (← links)
• Environmental and NSAID-enteropathy: dysbiosis as a common factor (Q38188487) (← links)
• Recent developments in chimeric NSAIDs as safer anti-inflammatory agents. (Q38260626) (← links)
• Rebamipide suppresses collagen-induced arthritis through reciprocal regulation of th17/treg cell differentiation and heme oxygenase 1 induction (Q38438986) (← links)
• A novel pH-controlled hydrogen sulfide donor protects gastric mucosa from aspirin-induced injury (Q38733697) (← links)
• Clinical importance of nonsteroidal anti-inflammatory drug enteropathy: the relevance of tumor necrosis factor as a promising target. (Q38809387) (← links)
• Non-cytochrome P450-mediated bioactivation and its toxicological relevance. (Q38929936) (← links)
• Gata4 is critical to maintain gut barrier function and mucosal integrity following epithelial injury. (Q40458744) (← links)
• The non-invasive exfoliated transcriptome (exfoliome) reflects the tissue-level transcriptome in a mouse model of NSAID enteropathy. (Q42778368) (← links)
• How close are we to developing enteric-protective drugs against non-steroidal anti-inflammatory drug-induced small intestinal injury? New mechanistic insight from preclinical models (Q43609300) (← links)
• Role of small intestinal bacterial overgrowth in severe small intestinal damage in chronic non-steroidal anti-inflammatory drug users (Q45262131) (← links)
• Non-steroidal anti-inflammatory drug-induced enteropathy. (Q45400230) (← links)
• GPR55 regulates intraepithelial lymphocyte migration dynamics and susceptibility to intestinal damage (Q46146528) (← links)
• Role of enterohepatic recirculation in drug disposition: cooperation and complications (Q46578287) (← links)
• FFA3 Activation Stimulates Duodenal Bicarbonate Secretion and Prevents NSAID-Induced Enteropathy via the GLP-2 Pathway in Rats. (Q46883506) (← links)
• Design and evaluation of bi-layer pump tablet of flurbiprofen solid dispersion for zero-order controlled delivery (Q47569867) (← links)
• A novel model for NSAID induced gastroenteropathy in rats. (Q47893028) (← links)
• Activation of intestinal GR-FXR and PPARα-UGT signaling exacerbates ibuprofen-induced enteropathy in mice. (Q48149341) (← links)
• Phenylbutazone induces equine glandular gastric disease without decreasing prostaglandin E2 concentrations. (Q48284277) (← links)
• Novel anti-inflammatory agents targeting CXCR4: Design, synthesis, biological evaluation and preliminary pharmacokinetic study (Q50870345) (← links)
• H2S confers colonoprotection against TNBS-induced colitis by HO-1 upregulation in rats. (Q53128579) (← links)
• Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits. (Q55071130) (← links)
• Nitric Oxide in the Gastrointestinal Tract: Opportunities for Drug Development (Q57790378) (← links)
• Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac (Q60907501) (← links)
• Toward More GI-Friendly Anti-Inflammatory Medications (Q85963163) (← links)
• Potential Strategies in the Prevention of Nonsteroidal Anti-inflammatory Drugs-Associated Adverse Effects in the Lower Gastrointestinal Tract (Q90233867) (← links)
• Synergistic protective effects between docosahexaenoic acid and omeprazole on the gastrointestinal tract in the indomethacin-induced injury model (Q104473120) (← links)